Sunday, June 14, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 1011 of 1,261

  1. US 7662592

    Bacteriocin inducer peptides

    The United States of America, as represented by the Secretary of Agriculture · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted

  2. US 7662395

    Method of enhancing a targeted immune response against tumors

    The United States of America, as represented by the Department of Health and Human Services · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted

  3. US 7662365

    Polymer conjugates of opioid antagonists

    Nektar Therapeutics · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted

  4. US 7662619

    Sol-fusin: use of GP64-6His to catalyze membrane fusion

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted

  5. US 7662779

    Triazolyl macrocyclic hepatitis C serine protease inhibitors

    Enanta Pharmaceuticals, Inc. · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted

  6. US 7662607

    Chalaropsis lysozyme protein and its method of use in anti-bacterial applications

    New Century Pharmaceuticals, Inc. · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted

  7. US 7662780

    Administering hypocretin to obese individuals

    The Regents of the University of California · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted

  8. US 7662815

    Diaryl ether β2 adrenergic receptor agonists

    Theravance, Inc. · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted

  9. US 7662923

    Modified vitamin K-dependent polypeptides

    Regents of the University of Minnesota · Granted Feb 16, 2010 · Expires Feb 11, 2030

    granted

  10. US 7659283

    Pyrrolo [3,2-C] pyridines useful as inhibitors of protein kinases

    Vertex Pharmaceuticals Incorporated · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted

  11. US 7659267

    1,3-Benzothiazinone derivatives, process for producing the same use thereof

    Takeda Pharmaceutical Company Limited · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted

  12. US 7658923

    Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26

    The Board of Regents of the University of Texas System · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted

  13. US 7659403

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted

  14. US 7659361

    Maleamic acid polymer derivatives and their bioconjugates

    Nektar Therapeutics · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted

  15. US 7659371

    Patched polypeptides and uses related thereto

    The Regents of the University of California · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted

  16. US 7659309

    Polymorphic forms of (1-{3-[3-(4-cyano-3-methoxy-phenyl) ureido]-phenyl}-ethyl)-carbamic acid-2-cyano-1-ethyl-ethyl ester

    Vertex Pharmaceuticals Incorporated · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted

  17. US 7659306

    Method of increasing gastric emptying

    The Board of Regents of the University of Texas System · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted

  18. US 7659285

    Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases

    ACADIA Pharmaceuticals Inc. · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted

  19. US 7659252

    Transdermal delivery peptides and method of use thereof

    UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted

  20. US 7659280

    2,4-pyrimidinediamine compounds for treating or preventing autoimmune diseases

    Rigel Pharmaceuticals, Inc. · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted

  21. US 7659278

    Use of low molecular weight compounds for preparing a medicament useful in treating mutant p53 mediated diseases

    APREA AB · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted

  22. US 7659268

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted

  23. US 7659269

    Substituted indolealkanoic acids

    The Institute for Pharmaceutical Discovery, LLC · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted

  24. US 7658551

    Optical fiber connector

    Advanced Connectek Inc. · Granted Feb 9, 2010 · Expires Feb 4, 2030

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.